CSL Limited

On Friday, the Australian market closed higher, lifted by the news of a massive joint venture between mining giants BHP Billiton and Rio Tinto after Rio scrapped the takeover deal with Chinalco. The benchmark S&P/ASX200 index was up 36.6 points, or 0.93 per cent, at 3971.2, while the broader All Ordinaries index gained 36.5 points, or 0.93 per cent, to 3969.0 points. Today the local market could be hit by lower commodities prices.

The Australian share market closed lower with a broad-based selling off after Wall Street's tumble. The benchmark S&P/ASX200 index slumped 45.4 points, or 1.2 per cent, at 3755.7, while the broader All Ordinaries index lost 41.4 points, or 1.1 per cent, to 3753.9.

The Australian share market yesterday closed slightly higher with a good lead from Wall Street. The benchmark S&P/ASX200 index gained 12.7 points, or 0.3 per cent, at 3801.1, while the broader All Ordinaries index rose 13.7 points, or 0.4 per cent, to 3795.3. There was a sell-off in late trading as investors drew cash to participate ANZ's capital raising.

The Australian share market ended lower on Friday, dragged by the big miners, as global demand worries hit the prices of oil and base metals. The benchmark S&P/ASX200 index fell 52.3 points, or 1.37 per cent, at 3,761.6, while the broader All Ordinaries index lost 49.3 points, or 1.3 per cent, to 3,755.4. Resources stocks are expected to gain as commodities prices were firmer. The Australian Securities and Investments Commission will lift a ban on covered short-selling of financial stocks effective from the opening of trade today.

Yesterday Australian shares plunged sharply, dragged by financial stocks as investors feared the UK banks might need to raise more funds. The unfavorable corporate earnings results also weighed down the market. The benchmark S&P/ASX200 was down 1.5%, or 52.6 points, to 3464.3, while the broader All Ordinaries index lost 1.4%, or 49.1 points, to 3412.2.

The Australian share market closed higher on Tuesday. The benchmark S&P/ASX200 index rose 27.5 points to 5053.6, while the broader All Ordinaries rose 21 points to 5090.3.

Clinical Cell Culture Ltd (ASX: CCE) today announced that it had entered into a supply agreement with CSL Limited (ASX: CSL) for the supply of Trypsin, a key component of the Company's ReCell(R) tissue harvesting device.

Summary of Australian Companies Profit Percentages offshore investments.